AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 3, 2004, Pages 353-366

  Jiang, S ^a   Khan, M I ^a   Middlemiss, P J ^a   Lu, Y ^a   Werstiuk, E S ^a   Crocker, C E ^b   Ciccarelli, R ^c   Caciagli, F ^c   Rathbone, M P ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

AIT 082; Gliosis; Histology; Locomotor function; Methylprednisolone (MPSS); Spinal cord injury

Indexed keywords

LETEPRINIM; METHYLPREDNISOLONE;

ACUTE DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; EDEMA; HISTOPATHOLOGY; LOCOMOTION; MACROPHAGE; MICROGLIA; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; TIME SERIES ANALYSIS;

EID: 8344280353     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700315     Document Type: Article

References (64)

1. Ramer M.S., J.V. Priestley and S.B. McMahon. 2000. Functional regeneration of sensory axons into the adult spinal cord.[comment]. Nature 403:312.
2. Blight A.R. and M.P. Zimber. 2001. Acute spinal cord injury: pharmacotherapy and drug development perspectives. Curr. Opin. Investig. Drugs 2:801.
3. Becker D., C.L. Sadowsky and J.W. McDonald. 2003. Restoring function after spinal cord injury. Neurolog. 9:1.
4. Blight A.R. 2002. Miracles and molecules-progress in spinal cord repair. Nat. Neurosci. 5(S):1.
5. Braughler J.M. and E.D. Hall. 1984. Effects of multidose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61:290.
6. Hall E.D., D.L. Wolf and J.M. Braughler. 1984. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis. J. Neurosurg. 61:124.
7. Young W., V. DeCrescito, E.S. Flamm, A.R. Blight and J.A. Gruner. 1988. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clin. Neurosurg. 34:675.
8. Constantini S. and W. Young. 1994. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80:97.
9. Merola A., M.F. O'Brien, B.A. Castro, D.A. Smith, J.M. Eule, T.G. Lowe, A.P. Dwyer, T.R. Haher and N.J. Espat. 2002. Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone. J. Orthop. Traumatol. 16:155.
10. Wrathall J.R., Y.D. Teng and D. Choiniere. 1996. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp. Neurol. 137:119.
11. McDonald J.W. 1999. Repairing the damaged spinal cord. Sci. Am. 281:64.
12. Li S. and P.K. Stys. 2000. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 20:1190.
13. Bracken M.B., M.J. Shepard, T.R. Holford, L. Leo-Summers, E.F. Aldrich, M. Fazl, M.G. Fehlings, D.L. Herr, P.W. Hitchon, L.F. Marshall, R.P. Nockels, V. Pascale, P.L. Perot, Jr., J. Piepmeier, V.K. Sonntag, F. Wagner, J.E. Wilberger, H.R. Winn and W. Young. 1998. Methylprednisolone or tirilazad mesylate administrations after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89:699.
14. Bracken M.B. 2001. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. [comment]. Spine. 26(S):1.
15. Bracken M.B. and T.R. Holford. 1993. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2.[comment]. J. Neurosurg. 79:500.
16. Glasky. A.J., C.L. Melchior, B. Pirzadeh, N. Heydari and R.F. Ritzmann. 1994. Effect of AIT-082, a purine analog, on working memory in normal and aged mice. Pharmacol. Biochem. Behav. 47:325.
17. Wang X., N. Hauptmann, E. Taylor, M. Foreman, L.A. Khawli and M.D. Maines. 2003. Neotrofin increases heme oxygenase-1 selectively in neurons. Brain Res. 962:1.
18. Juurlink B.H. and P.G. Paterson. 1998. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J. Spinal Cord Med. 21:309.
19. Ciccarelli R., P. Di Iorio, I. D'Alimonte, S. Kleywegt, P. Ballerini, M. P. Rathbone, A. Poli and F. Caciagli. 1999. Guanosine and related drugs stimulate the production of neurotrophic factors from rat cultured astrocytes by involving mitogen-activated protein kinase pathway. Soc. Neurosci. (Abstr.) 25:1013.
20. Di Iorio P., A. Virgilio, P. Giuliani, P. Ballerini, G. Vianale, P.J. Middlemiss, M.P. Rathbone and R. Ciccarelli. 2001. AIT-082 is neuroprotective against kainate-induced neuronal injury in rats. Exp. Neurol. 169:392.
21. Taylor E.M., R. Yan, N. Hauptmann, T.J. Maher, D. Djahandideh and A.J. Glasky. 2000. AIT-082, a cognitive enhancer, is transported into brain by a nonsaturable influx mechanism and out of brain by a saturable efflux mechanism. J. Pharm. Exp. Ther. 293:813.
22. Middlemiss P. J., M. Imitiaz, S. Jang, A. Mintz, C. Almas, C. Crocker, T.P. S. Virk and M. P. Rathbone. 1999. The synthetic purine AIT-082 enhances recovery after acute spinal cord crush injury in rats. Soc. Neurosci. (Abstr.) 25:1002.
23. Blight A.R. 1991. Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 103:156.
24. Gruner J.A., A.K. Yee and A.R. Blight. 1996. Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res. 729:90.
25. Shi R., T.M. Kelly and A.R. Blight. 1997. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp. Neurol. 148:495.
26. Luo J., R. Borgens and R. Shi. 2002. Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochem. 83:471.
27. Basso D.M., M.S. Beattie and J.C. Bresnahan. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12:1.
28. Basso D.M., M.S. Beattie, J.C. Bresnahan, D.K. Anderson, A.I. Faden, J.A. Gruner, T.R. Holford, C.Y. Hsu, L.J. Noble, R. Nockels, P.L. Perot, S.K. Salzman and W. Young. 1996. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 13:343.
29. Kerasidis H., J.R. Wrathall and K. Gale. 1987. Behavioral assessment of functional deficit in rats with contusive spinal cord injury. J. Neurosci. Meth. 20:167.
30. Rivlin A.S. and C.H. Tator. 1977. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47:577.
31. Bresnahan J.C., M.S. Beattie, F.D. Todd III and D.H. Noyes. 1987. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95:548.
32. Bruck W., T. Kuhlmann and C. Stadelmann. 2003. Remyelination in multiple sclerosis. J. Neurol. Sci. 206:181.
33. Basso D.M. 2000. Neuroanatomical substrates of functional recovery after experimental spinal cord injury: implications of basic science research for human spinal cord injury. Phys. Ther. 80:808.
34. Saruhashi Y. and W. Young. 1994. Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats. Exp. Neurol. 129:207.
35. Faden A.I. and S.K. Salzman. 1994. Experimental pharmacology. In S.K. The Neurobiology of Central Nervous System Trauma, Salzman and A.I. Faden, ed. Oxford University Press. New York, p. 227.
36. Reier P.J. and J.D. Houle. 1988. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 47:87.
37. Miller R.H. and F.J. Liuzzi. 1986. Regional specialization of the radial glial cells of the adult frog spinal cord. J. Neurocytol. 15:187.
38. Morin-Richaud C., S. Feldblum and A. Privat. 1998. Astrocytes and oligodendrocytes reactions after a total section of the rat spinal cord. Brain Res. 783:85.
39. Feldblum S., S. Arnaud, M. Simon, O. Rabin and P. D'Arbigny. 2000. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury. J. Neurotrauma 17:1079.
40. Ray S.K., D.D. Matzelle, G.G. Wilford, E.L. Hogan and N.L. Banik. 2001. Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 916:115.
41. Dong Y. and E.N. Benveniste. 2001. Immune Function of Astrocytes. GLIA 36:180.
42. Park J., D. Kwon, C. Choi, J.W. Oh and E.N. Benveniste. 2003. Choroquine induces activation of nuclear factor-kB and subsequent expression of proinflammatory cytokines by human astroglial cells. J. Neurochem. 84:1266.
43. Wang X., L. Xu, H. Wang, Y. Zhan, E. Pure and G.Z. Feuerstein. 2002. CD44 deficiency in mice protects brain from cerebral ischemia injury. J. Neurochem. 83:1172.
44. Eskes C., P. Honegger, L. Juillerat-Jeanneret and F. Monnet-Tschudi. 2002. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. GLIA 37:43.
45. Tilgner J., B. Volk and C. Kaltschmidt. 2001. Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis. GLIA 35:234.
46. Chikawa T., T. Ikata, S. Katoh, Y. Hamada, K. Kogure and K. Fukuzawa. 2001. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. J. Neurotrauma 18:93.
47. Xu J., G. Fan, S. Chen, Y. Wu, X.M. Xu, and C.Y. Hsu. 1998. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res. Mol. Brain Res. 59:135.
48. Rathbone M.P., P. Middlemiss, C. Andrew, F. Caciagli, R. Ciccarelli, P. Di Iorio, and R. Huang. 1998. The trophic effects of purines and purinergic signaling in pathologic reactions of astrocytes. Alzheimer Dis. Assoc. Dis. 12(S):1
49. Rathbone M.P., P.J. Middlemiss, J.W. Gysbers, C. Andrew, M.A. Herman, J.K. Reed, R. Ciccarelli, P. Di Iorio and F. Caciagli. 1999. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59:663.
50. Baranano D.E. and S.H. Snyder. 2001. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 98:10996.
51. Bracken M.B. 1992. Pharmaological treatment of acute spinal cord injury: current status and future prospects. Paraplegia. 30:102.
52. Behrmann D.L., J.C. Bresnahan and M.S. Beattie. 1994. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp. Neurol. 126:61.
53. Bartholdi D. and M.E. Schwab. 1995. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:177.
54. Mabon P.J., L.C. Weaver and G.A. Dekaban. 2000. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alpha D: a potential new anti-inflammatory treatment. Exp. Neurol. 166:52.
55. Amar A.P. and M.L. Levy. 1999. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44:1027.
56. Rabchevsky A.G., I. Fugaccia, P.G. Sullivan, D.A. Blades and S.W. Scheff. 2002. Efficacy of methylprednisolone therapy for the injured rat spinal cord. J. Neurosci. Res. 68:7.
57. Hall E.D. 1992. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76:13.
58. Olson J.J., M.M. Poor Jr. and D.W. Beck. 1988. Methylprednisolone reduces the bulk flow of water across an in vitro blood-brain barrier. Brain Res. 439:259.
59. McLeish K.R., F.N. Miller, G.T. Stelzer and S.R. Wellhausen. 1986. Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeability. Inflammation 10:321.
60. Crossin K.L., M.H. Tai, L.A. Krushel, V.P. Mauro, and G.M. Edelman. 1997. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. U.S.A. 94:2687.
61. Alonso G. 2000. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. GLIA 31:219.
62. Simard M., W.T. Couldwell, W. Zhang, H. Song, S. Liu, M.L. Cotrina, S. Goldman and M. Nedergaard. 1999. Glucocorticoids-potent modulators of astrocytic calcium signaling. GLIA 28:1.
63. Harkey H.L., W.A. White, R.E. Tibbs and D.E. Haines. 2003. A clinicina's view of spinal cord injury. Anatomical Record 271B:41.
64. Hugenholtz H., D.E. Cass, M.F. Dvorak, D.H. Fewer, R.J. Fox, D.M. Izukawa, J. Lexchin, S. Tuli, N. Bharatwal and C. Short. 2002. High-dose methylprednisolone for acute closed spinal cord injury-only a treatment option. Can. J. Neurol. Sci. 29:227.